Patent ID: 9642880
Date: 2017-05-09
CPC Classifications: A01N,A61K,A61P,B65B,C12N,C12Q,Y02A

Claim:
1. A method for treating ulcerative colitis, the method comprising: administering a microbiota restoration therapy composition to a patient with ulcerative colitis; wherein the microbiota restoration therapy composition is pre-screened for bacterial diversity; wherein the pre-screened microbiota restoration therapy composition includes bacteria from at least seven different families and has a Shannon Diversity Index of 0.4-2.5 when calculated at the family level; and wherein the microbiota restoration therapy composition comprises a mixture of an effective amount of fecal microbiota from a fresh human fecal sample and a mixture of polyethylene glycol and saline, the polyethylene glycol added to the fresh human stool sample at a concentration of 30-90 g/L.